Internal Medicine, Medical Oncology · Hackensack, NJ
NPI
1457310815
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
92 2nd St
Hackensack, NJ, 07601
Phone (551) 996-8704
Groups this clinician bills Medicare through
Medicare paid, 2024
$315K
5,509 services
Medicare patients, 2024
564
Average age 75
Drug cost, 2024
$9.0M
927 prescriptions
Company payments, 2025
$8,430
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Siegel was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,503 times for 523 patients. In total David S Siegel billed 5,509 services in 17 codes, and Medicare paid $315K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,503 | 523 | $13.78 | $21K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,340 | 16 | $6.18 | $8,287 |
| 99215 Office E&M - Established | Office | 1,239 | 395 | $150.14 | $186K |
| 99214 Office E&M - Established | Office | 568 | 347 | $102.92 | $58K |
| 96372 Injection Administration | Office | 54 | 29 | $12.37 | $668 |
| 99205 Office E&M - New | Office | 29 | 29 | $184.38 | $5,347 |
| 38221 Other Organ Systems | Office | 29 | 25 | $144.55 | $4,192 |
| 38220 Other Organ Systems | Office | 29 | 25 | $69.96 | $2,029 |
| 85097 Test - Miscellaneous | Office | 28 | 26 | $60.54 | $1,695 |
By year: 2022 $318K for 6,763 services; 2023 $328K for 7,851 services; 2024 $315K for 5,509 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,148 | 410 | $7.43 | $8,531 |
| 85027 Blood Count | 61 | 48 | $6.39 | $390 |
Medicare prescription drug claims, 2024
In 2024, the drug David S Siegel prescribed most often to Medicare patients was Pomalyst (Pomalidomide), with 271 prescriptions and refills. In total David S Siegel wrote 927 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pomalyst Pomalidomide | 271 | 272 | 89 | $5.0M |
| Revlimid Lenalidomide | 145 | 145 | 65 | $2.4M |
| Valacyclovir Valacyclovir Hcl | 112 | 217 | 49 | $4,685 |
| Dexamethasone Generic | 59 | 65 | 25 | $825 |
| Brukinsa Zanubrutinib | 46 | 46 | Under 11 | $685K |
| Acyclovir Generic | 41 | 85 | 19 | $366 |
| Lenalidomide Generic | 40 | 41 | 16 | $459K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 27 | 36 | 11 | $91.18 |
| Xarelto Rivaroxaban | 27 | 32 | Under 11 | $17K |
| Ninlaro Ixazomib Citrate | 18 | 18 | Under 11 | $234K |
| Eliquis Apixaban | 13 | 16 | Under 11 | $9,118 |
| Fentanyl Generic | 13 | 13 | Under 11 | $579 |
| Alprazolam Generic | 12 | 12 | Under 11 | $57.64 |
| Tramadol Hcl Generic | 12 | 12 | Under 11 | $30.84 |
| Cholestyramine Cholestyramine (With Sugar) | 11 | 16 | Under 11 | $763 |
Brand drugs: 538 claims; generic drugs: - claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Siegel $8,430 ($8,430 in general payments such as food, travel and fees) from 13 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $3,324.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $3,324 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $2,913 |
| Janssen Biotech, Inc. JNJ | 3 | $1,331 |
| Genzyme Corporation SNY | 4 | $410 |
| Pfizer Inc. PFE | 7 | $133 |
| Karyopharm Therapeutics Inc. KPTI | 1 | $114 |
| Legend Biotech USA Inc. LEGN | 1 | $91.05 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $64.54 |
| Abbvie Inc. ABBV | 2 | $35.24 |
| BeiGene USA, Inc. ONC | 1 | $14.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.